| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/05/2010 | CA2748937A1 Urine and serum biomarkers associated with diabetic nephropathy |
| 08/05/2010 | CA2748852A1 Biomarkers associated with nephropathy |
| 08/04/2010 | EP2214016A1 Antibody directed against pro-gastrin releasing peptide, and use thereof |
| 08/04/2010 | EP2213743A1 Albumin fusion proteins |
| 08/04/2010 | EP2213742A1 Chimeric antigens for breaking host tolerance to foreign antigens |
| 08/04/2010 | EP2213740A1 Human telomerase catalytic subunit |
| 08/04/2010 | EP2213686A1 Tumor markers and methods of use thereof |
| 08/04/2010 | EP2213685A1 Therapeutic anti-IL-1R1 monoclonal antibody |
| 08/04/2010 | EP2213684A2 Nogo-a antibodies for the treatment of Alzheimer disease |
| 08/04/2010 | EP2213683A1 Variant Fc regions |
| 08/04/2010 | EP2213682A1 TSLP promotes immune evasion and persistence of viruses |
| 08/04/2010 | EP2213302A2 DR4 antibodies and uses thereof |
| 08/04/2010 | EP2213297A1 Staphylococcus aureus antigenic polypeptides |
| 08/04/2010 | EP2212432A2 Fully human anti-vegf antibodies and methods of using |
| 08/04/2010 | EP2212431A2 Antibodies to irem-1 |
| 08/04/2010 | EP2212416A1 Uses of a glycoprotein vi (gpvi) inhibitor |
| 08/04/2010 | EP2212412A1 Methods of manufacturing a biologic using a stable storage intermediate |
| 08/04/2010 | EP2212353A1 Antibody fragments inhibiting hiv nef protein |
| 08/04/2010 | EP2212350A1 Therapeutic and diagnostic methods using tim-3 |
| 08/04/2010 | EP2211904A2 Cd19 binding agents and uses thereof |
| 08/04/2010 | EP2211903A1 Antibodes to cll-1 |
| 08/04/2010 | EP2211889A2 Antibody-mediated disruption of quorum sensing in bacteria |
| 08/04/2010 | EP1864129B1 Doxorubicin immunoassay |
| 08/04/2010 | EP1819736B1 Use of endosialin binding proteins to isolate endosialin positive cells |
| 08/04/2010 | EP1711834B1 Process for screening glycoform-specific antibodies |
| 08/04/2010 | EP1694360B1 Use of antagonist anti-cd40 antibodies for treatment of autoimmune and inflammatory diseases and organ transplant rejection |
| 08/04/2010 | EP1572931B1 Methods and compositions for modulating and detecting wisp activity |
| 08/04/2010 | EP1531862B1 Stabilized liquid anti-rsv antibody formulations |
| 08/04/2010 | EP0904350B1 Modified rapid expansion methods ("modified-rem") for in vitro propagation of t lymphocytes |
| 08/04/2010 | CN101796415A Novel liver cancer marker |
| 08/04/2010 | CN101796074A Anti-notch1 NRR antibodies and methods using same |
| 08/04/2010 | CN101796073A Humanized antibodies against CXCR3 |
| 08/04/2010 | CN101796072A Amino acid sequences directed against RANK-l and polypeptides comprising the same for the treatment of bone diseases and disorders |
| 08/04/2010 | CN101792750A Yolk antibody for resisting activity of alpha-glucosidase and antigen, preparation method and application thereof |
| 08/04/2010 | CN101792746A Vascular peroxidase ELISA kit used for coronary disease diagnosis |
| 08/04/2010 | CN101792745A Expression and purification of influenza virus polymerase PA N-terminal polypeptide and crystal structure thereof |
| 08/04/2010 | CN101792738A Cell strain of monoclonal antibody against ciprofloxacin and monoclonal antibody thereof |
| 08/04/2010 | CN101791405A Method for preparing yolk immunoglobulin vaccine for resisting porphyromonas gingivalis |
| 08/03/2010 | US7767800 Comprises lymphadenopathy viral sequences for diagnosis of aquired immuno-depressive syndromes |
| 08/03/2010 | US7767794 5-fluoro-uracil immunoassay |
| 08/03/2010 | US7767793 Monolconal antibody specific to single immunoglobulin and toll-interleukin-1 receptor domain (SIGIRR) for treatment of rheumatoid arthritis, osteoporosis and inflammatory bowel diseases |
| 08/03/2010 | US7767791 Methods, products and treatments for diabetes |
| 08/03/2010 | US7767790 Apotosis inducing viral protein, in combination with defective p53 protein, for use in treatment of cell proliferative and autoimmune disorders |
| 08/03/2010 | US7767789 Truncated proteins as cancer markers |
| 08/03/2010 | US7767450 Nucleotide sequences coding voltage-gated transport proteins for use as screening tools to identify modulators for treatment and prevention of nervous, muscular, glandular, immune, reproductive and epithelial tissue disorders |
| 08/03/2010 | US7767429 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes; transgenic animals; dosage forms; HYLENEX RECOMBINANT tradename |
| 08/03/2010 | US7767405 Using glycosphingolipid GD2 specific immunoglobulin to treat cell proliferative disorders; immunotherapy; tissue targeted therapy |
| 08/03/2010 | US7767403 Binding monoclonal, humanized, or fragment of antibody to human cell that expresses a protein; cancer |
| 08/03/2010 | US7767398 Nucleotide sequences comprising mutation in untranslated coding region of ATP-gated ion channel (P2X7R) for use as tool in diagnosing psychological disorders |
| 08/03/2010 | US7767397 Hepoxilins and modulators of ichthyin for treatment skin disorders |
| 08/03/2010 | US7767392 Nucleotide sequences coding zinc finger protein for use in identifying modulators of cell proliferation disorders; antitumor agents |
| 08/03/2010 | US7767211 S.aureus polypeptides |
| 08/03/2010 | US7767207 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders |
| 08/03/2010 | US7767206 Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto |
| 08/03/2010 | US7767205 Erythropoietin-producing hepatocellullar kinase (EPH) specific immunoglobulin for use in treatment and prevention of tumor, cancer and/or cell proliferative disorders |
| 08/03/2010 | US7767194 Using cyanine dyes; in situ supplying to tumor cells |
| 08/03/2010 | CA2412183C Rtvp based compositions and methods for the treatment of prostate cancer |
| 08/03/2010 | CA2401342C Human antibodies against eotaxin and their use |
| 08/03/2010 | CA2359776C Methods for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance p by using anti-substance p antibodies |
| 08/03/2010 | CA2263106C Humanized immunoglobulin reactive with .alpha.4.beta.7 integrin |
| 08/03/2010 | CA2262423C Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen |
| 08/03/2010 | CA2224777C New immunoregulatory protein lst-1 |
| 08/03/2010 | CA2190365C Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |
| 08/03/2010 | CA2178057C Epstein-barr virus peptides and antibodies against these peptides |
| 08/03/2010 | CA2133873C Tnf inhibitors |
| 07/29/2010 | WO2010085590A1 Opsonic and protective antibodies specific for lipoteichoic acid gram positive bacteria |
| 07/29/2010 | WO2010085510A1 Antibody mediated osseous regeneration |
| 07/29/2010 | WO2010084197A1 Methods for producing mixtures of antibodies |
| 07/29/2010 | WO2010084158A1 Anti-cd 160 monoclonal antibodies and uses thereof |
| 07/29/2010 | WO2010065079A3 Antibodies to il-6 and use thereof |
| 07/29/2010 | WO2010064208A3 Msp2 antigenic peptides and their use |
| 07/29/2010 | WO2010064012A3 Treatment of autoimmune disease by modulating annexin-i (lipocortin 1 ) |
| 07/29/2010 | WO2010063785A3 Antibody variants having modifications in the constant region |
| 07/29/2010 | WO2010045495A3 Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof |
| 07/29/2010 | WO2010020766A3 Interleukin fusion polypeptides |
| 07/29/2010 | WO2010016943A3 Nutrient monitoring and feedback control for increased bioproduct production |
| 07/29/2010 | WO2009149487A3 Compounds for treating symptoms associated with parkinson's disease |
| 07/29/2010 | WO2006009890A9 Methods and compositions for producing insulin sensitization |
| 07/29/2010 | US20100192238 Elongases and methods for producing polyunsaturated fatty acids in transgenic organisms |
| 07/29/2010 | US20100190966 Method for immobilizing glycoprotein |
| 07/29/2010 | US20100190965 Method for separation of immunoglobulin monomers |
| 07/29/2010 | US20100190964 Antibodies to human ErbB4 |
| 07/29/2010 | US20100190963 Stirred Tank Reactor And Method |
| 07/29/2010 | US20100190962 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 07/29/2010 | US20100190961 Process for the purification of fc-containing proteins |
| 07/29/2010 | US20100190838 Connective Tissue Growth Factor Fragments and Methods and Uses Thereof |
| 07/29/2010 | US20100190655 Fusion polypeptide for detection of conserved combinatorial or composite epitopes in non-conserved proteins |
| 07/29/2010 | US20100190650 Transcriptomic biomarker of myocarditis |
| 07/29/2010 | US20100190266 Method for measuring bonding activity of antibody which mimics antibody-dependent cell medicated cytotoxic activiy |
| 07/29/2010 | US20100190247 Methods of Generating Variant Proteins with Increased Host String Content |
| 07/29/2010 | US20100190234 methods for the formation of disulphide bonds |
| 07/29/2010 | US20100190210 Protein Purification |
| 07/29/2010 | US20100190195 Use of Hepatitis B X-Interacting Protein (HBXIP) in Modulation of Apoptosis |
| 07/29/2010 | US20100190192 Method of diagnosing pre-eclampsia |
| 07/29/2010 | US20100190185 Novel non-invasive marker for liver function and disease |
| 07/29/2010 | US20100190164 Diagnosis and monitoring of renal failure using peptide biomarkers |
| 07/29/2010 | US20100190163 Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them |
| 07/29/2010 | US20100190161 Mutations in human ubiad1 |
| 07/29/2010 | US20100189776 Anti-androgen peptides and uses thereof in cancer therapy |
| 07/29/2010 | US20100189727 Masking Ligands For Reversible Inhibition Of Multivalent Compounds |